Kliniska studier för Lymfom i Missouri
17 studier för Lymfom söker deltagare vid platser i Missouri.
Städer i Missouri
Officiell studietext (engelska)
A First-in-Human Study of KK2223 in Participants With Relapsed or Refractory T Cell Non-Hodgkin Lymphoma
- Washington University School of Medicine - Oncology Hospital - Public, St Louis
RekryterarFas 1
Ålder 18 och äldre · Alla kön · Uppdaterad 30 sep. 2026 · NCT07192471A Study of the Efficacy and Safety of Lisocabtagene Maraleucel (Liso-cel) as First-Line Therapy in Adults With Transplant-Ineligible Primary Central Nervous System Lymphoma
- Washington University School of Medicine in St. Louis, St Louis
RekryterarFas 2
Ålder 18 och äldre · Alla kön · Uppdaterad 30 sep. 2026 · NCT07015242A Study of Repotrectinib in Pediatric and Young Adult Subjects Harboring ALK, ROS1, OR NTRK1-3 Alterations
- Washington University School of Medicine in St. Louis, St Louis
RekryterarFas 1/2
Upp till ålder 25 · Alla kön · Uppdaterad 25 sep. 2026 · NCT04094610Testing the Addition of an Anti-cancer Drug, Lenalidomide, to the Usual Combination Chemotherapy Treatment ("EPOCH") for Adult T-Cell Leukemia-Lymphoma (ATLL)
- Siteman Cancer Center at Saint Peters Hospital, City of Saint Peters
- Siteman Cancer Center at West County Hospital, Creve Coeur
- Washington University School of Medicine, St Louis
- och 1 fler
RekryterarFas 1
Ålder 18 och äldre · Alla kön · Uppdaterad 23 sep. 2026 · NCT04301076Collection of Tissue Samples for Cancer Research
- Washington University - St. Louis, St Louis
RekryterarObservationsstudie
2 Months · Alla kön · Uppdaterad 16 sep. 2026 · NCT00900198CBL0137 for the Treatment of Relapsed or Refractory Solid Tumors, Including CNS Tumors and Lymphoma
- Children's Mercy Hospitals and Clinics, Kansas City
- Washington University School of Medicine, St Louis
RekryterarFas 1/2
12 Months – 21 Years · Alla kön · Uppdaterad 11 sep. 2026 · NCT04870944TLN-121 in Relapsed or Refractory Non-Hodgkin Lymphomas
- Washington University School of Medicine, St Louis
RekryterarFas 1
Ålder 18 och äldre · Alla kön · Uppdaterad 4 sep. 2026 · NCT07082803A Study to Evaluate Glofitamab as a Single Agent vs. Investigator's Choice in Participants With Relapsed/Refractory Mantle Cell Lymphoma
- St. Luke's Hospital, Chesterfield
RekryterarFas 3
Ålder 18 och äldre · Alla kön · Uppdaterad 3 sep. 2026 · NCT06084936A Phase 1 Study of UB-VV111 With and Without Rapamycin in Relapsed/Refractory CD19+ B-cell Malignancies
- Washington University School of Medicine/Siteman Cancer Center, St Louis
RekryterarFas 1
Ålder 18 och äldre · Alla kön · Uppdaterad 17 aug. 2026 · NCT06528301DALY II USA/ MB-CART2019.1 for DLBCL
- Washington University, St. Louis, St Louis
RekryterarFas 2
Ålder 18 och äldre · Alla kön · Uppdaterad 13 juli 2026 · NCT04792489An AI-Generated, Personalized Question Prompt List Intervention for Patients With Hematologic Cancers
- Washington University School of Medicine, St Louis
Rekryterar
Ålder 18 till 99 · Alla kön · Uppdaterad 1 juni 2026 · NCT07226934Effects of Dexrazoxane Hydrochloride on Biomarkers Associated With Cardiomyopathy and Heart Failure After Cancer Treatment
- Washington University School of Medicine, St Louis
RekryterarObservationsstudie
Alla åldrar · Alla kön · Uppdaterad 18 maj 2026 · NCT01790152Post-Op Pain Control for Prophylactic Intramedullary Nailing.
- Saint Louis University, St Louis
RekryterarFas 3
Ålder 18 och äldre · Alla kön · Uppdaterad 22 apr. 2026 · NCT03823534BRAZAN: A Randomized Phase 2 Study of Bendamustine, Rituximab, Cytarabine (AraC) Induction With Zanubrutinib (BRAZAN) Followed by Zanubrutinib/Rituximab +/- Sonrotoclax Maintenance in Treatment-Naïve Mantle Cell Lymphoma
- Washington University, St Louis
RekryterarFas 2
Ålder 18 och äldre · Alla kön · Uppdaterad 20 feb. 2026 · NCT06854003Geriatric Evaluation and Management With Survivorship Health Education for Older Survivors of Cancer, GEM-S Trial
- Lake Regional Hospital, Osage Beach
RekryterarFas 3Friska volontärer välkomna
Ålder 18 och äldre · Alla kön · Uppdaterad 13 jan. 2026 · NCT05006482A Safety and Efficacy Study Evaluating CTX112 in Subjects With Relapsed or Refractory B-Cell Malignancies
- Washington University, St Louis
RekryterarFas 1/2
Ålder 18 och äldre · Alla kön · Uppdaterad 14 nov. 2025 · NCT05643742A Randomized Phase II Study Of Bruton Tyrosine Kinase Inhibitor With Or Without Venetoclax In Veterans With Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL)
- Kansas City VA Medical Center, Kansas City, MO, Kansas City
RekryterarFas 2
Ålder 18 till 80 · Alla kön · Uppdaterad 14 okt. 2025 · NCT06520098Från ClinicalTrials.gov, data hämtad 5 okt. 2026. Varje studie har egna kvalifikationskrav; studieteamet avgör vem som kan delta.